Sanatorio 9 de Julio - Tucumán
Con más de 60 años de vida el Sanatorio 9 de Julio es el mayor establecimiento asistencial privado de la provincia de Tucumán y uno de los mayores del interior del país. Se trata de una organización clave y esencial para el sistema de salud de la Provincia de TucumánSan Juan 537, San Miguel de Tucumán, CP 4000
Select an option
I am a doctor
I am a sponsor
Specializations
Diabetes
Colitis ulcerosa
Enfermedad de Crohn
Our team
Medical staff
María Flavia Figueroa
Susana del Valle Carreño Rimaudo
Hector Raul Sueldo
Abel Novillo
Paula Perez
Open studies
Lung cancer
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) - DeLLphi-306 - AmgenSee more
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) - GlaxoSmithKlineSee more
Myeloproliferative syndromes
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006) - Merck Sharp & Dohme LLCSee more
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007) - Merck Sharp & Dohme LLCSee more
Breast Cancer
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) - VIKTORIA-1 - Celcuity, Inc.See more
Interstitial Lung Disease
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease - BEconneCTD-ILD - GlaxoSmithKlineSee more
Multiple myeloma
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) - SUCCESSOR-2 - Bristol-Myers SquibbSee more
Neutropenia
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections - X4P-001-110 - X4 PharmaceuticalsSee more
Rare diseases
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome - AmgenSee more
